Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study
about
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
Real life triplet FIr/FOx chem ...... and safety and phase II study
@en
Real life triplet FIr/FOx chem ...... and safety and phase II study
@nl
type
label
Real life triplet FIr/FOx chem ...... and safety and phase II study
@en
Real life triplet FIr/FOx chem ...... and safety and phase II study
@nl
prefLabel
Real life triplet FIr/FOx chem ...... and safety and phase II study
@en
Real life triplet FIr/FOx chem ...... and safety and phase II study
@nl
P2093
P2860
P356
P1433
P1476
Real life triplet FIr/FOx chem ...... and safety and phase II study
@en
P2093
Aldo Victor Giordano
Alessandra Di Sibio
Antonio Russo
Enrico Ricevuto
Eugenio Ciacco
Gemma Bruera
Oncology Network ASL1 Abruzzo, Italy
Rosa Manetta
Sergio Carducci
Silvia Massacese
P2860
P304
31861-31876
P356
10.18632/ONCOTARGET.25870
P407
P577
2018-08-07T00:00:00Z